Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$513K Hold
21,303
0.27% 31
2026
Q1
$598K Hold
21,303
0.35% 27
2025
Q4
$530K Sell
21,303
-115
-0.5% -$2.9K 0.28% 30
2025
Q3
$546K Hold
21,418
0.3% 29
2025
Q2
$519K Sell
21,418
-2,824
-12% -$65.9K 0.29% 31
2025
Q1
$614K Hold
24,242
0.35% 29
2024
Q4
$643K Buy
24,242
+1,915
+9% +$51.9K 0.37% 29
2024
Q3
$646K Hold
22,327
0.37% 30
2024
Q2
$625K Hold
22,327
0.4% 28
2024
Q1
$642K Buy
22,327
+11,150
+100% +$309K 0.38% 30
2023
Q4
$322K Hold
11,177
0.22% 43
2023
Q3
$371K Buy
11,177
+238
+2% +$8.42K 0.26% 36
2023
Q2
$401K Sell
10,939
-4,000
-27% -$156K 0.27% 36
2023
Q1
$581K Buy
+14,939
New +$645K 0.36% 37

Other funds holding PFE

Granite FO LLC's PFE Position: Q2 2026 in Review

Granite FO LLC held its Pfizer (PFE) position steady in Q2 2026 at 21,303 shares worth $513K. The position accounts for 0.27% of the portfolio, ranked #31.

Granite FO LLC first reported a position in PFE in Q1 2023 and has held it in 14 quarters since. The position peaked at $646K in Q3 2024. 1,342 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Granite FO LLC held 21,303 shares of Pfizer worth $513K as of Q2 2026.
  • Granite FO LLC left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.27% of Granite FO LLC's portfolio in Q2 2026, its #31 holding.
  • Granite FO LLC first reported a position in Pfizer in Q1 2023 and has held it in 14 quarters since.
  • Granite FO LLC's Pfizer position peaked at $646K in Q3 2024.
  • 1,342 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Granite FO LLC's 13F filing for Q2 2026, filed 15 Jul 2026.